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Subjective and objective sleep quality in non-demented elderly individuals: role of psychogeriatric 
evaluation. 
Abstract 
Aging affects sleep, and sleep problems are common in older individuals but the relationship between 
objective or subjective tool to analyse sleep and psycho-geriatric variables have not been in institutionalised 
older individuals. This work analyse sleep quality by means of objective tool (with actigraphy) and 
subjective perception of sleep by validates scales (measured with the Athens and Oviedo sleep 
questionnaires) in octogenarian non-demented elderly individuals. All patients wore an actigraph device for 
one week and then completed the Athens and Oviedo clinical sleep-evaluation questionnaires. Morning 
cortisol levels in blood plasma and saliva samples were also measured in order to assess any associations 
with the reported sleep patterns. Age, gender, and psycho-geriatric evaluations, including Barthel, Tinetti, 
and Mini-Mental scale measurements, were analysed as variables with the potential to confound the strength 
of such associations. There was a significant and inverse correlation between the number of awakenings 
during the night assessed by actigraphy or the time spent awake during night and the total Oviedo 
questionnaire score, but he other parameters were not. The concentration of blood cortisol appears of marker 
of insomnia, being related to sleep times of less than four hours and represent a potential marker for sleep 
interventions. 
 











Sleep disorders are common in elderly populations (Rodriguez et al., 2015) and aging can influence sleep 
patterns (Foley et al., 1995; Mellinger et al., 1985). When sleep alterations appear, they can significantly 
reduce quality of life and promote adverse outcomes in other pathologies (Sariarslan  et al., 2015). Although 
some older adults complain of poor night-time sleep and subsequent impairments in daytime functioning, 
others assume that their difficulties are part of the normal aging process and so do not complain about their 
sleep problems, even when the quality of their sleep is impaired. The mechanisms behind sleep 
misperception are still poorly understood and thus, the comparison of objective and subjective sleep quality 
has more recently become a research target in relation to different diseases, e.g. (Hasselberg et al., 2013; 
Chen et al., 2015; Klumpp et al., 2017), such as depression or diseases characterized by cognitive 
impairment, where both sleep quality and the perception of sleep are of paramount importance. 
  Because questionnaires are the most commonly used instruments for detecting sleep problems, it is 
crucial that subjective descriptions of sleep quality be correlated with its objective measurement with tools 
such as actigraph devices in order to implement interventions to improve sleep duration, maintenance, or 
sleep onset latency. Recent studies (Landry et al., 2015; Chen et al., 2015; Klumpp et al., 2017) used 
actigraphy as an objective measurement of sleep quality because technological advances in actigraph 
instruments have improved their precision in measuring sleep in patients’ normal environments (e.g., at 
home) for long periods of time. In contrast, polysomnography can only be administered for very small 
periods of time, and the sleep is assessed outside patients’ normal contexts (e.g., in a hospital). In this latter 
technique, patients are hooked up to machines via up to 20 electrodes placed on their body and head, in a 
laboratory setting with cameras rather than in their own bed. Hence, in this context, it is understandable that 
subjects might not sleep normally. Moreover, recent validation studies focusing on actigraphy have justified 
their use as an objective measurement of sleep, e.g. (Meadows et al., 2010; Meltzer et al., 2016).  
 Many sleep-related disorders are underdiagnosed in older individuals, and others respond poorly to 
pharmacological treatments. Moreover, psychotropic drugs can induce a wider variety of side effects in 
older individuals compared to younger populations and so it is important to evaluate their utility in the 
management of sleep problems specifically in older individuals. Therefore, the main aim of this present 
study was to perform a focused evaluation of sleep quality, correlating objective measurement (actigraphy) 
and the corresponding subjective evaluation tool (Oviedo and Athens questionnaire) results, in relation to 




individuals (Castello-Domenech et al., 2016; Vgontzas et al., 1999; Kushida, 2004; Bush & Hudson, 2010) 
we also evaluated the relationship between the morning concentration of cortisol in blood and saliva in these 
patients and their sleep quality. Thus, we investigated the following three objectives: 
(1) Evaluate sleep quality in older institutionalized individuals by actigraphy and validated sleep-related 
questionnaires.  
(2) Evaluate the relationship between sleep quality and psycho-geriatric evaluation.  
(3) Evaluate the association between morning cortisol concentrations and sleep quality and efficiency.  
2. Methods 
2.1. Design and study population 
This was a cross-sectional design research study conducted between 2014 and 2016 with institutionalized 
elderly individuals living in different nursing homes located in Valencia and its province (GeroResidencias 
La Saleta, Valencia). The inclusion criteria were: institutionalization for at least 6 months, ability to 
understand the sleep-quality questionnaire questions, and age of 60 years or older. The exclusion criteria 
were severe cognitive impairment or inability to speak, poorly-controlled psychiatric disease (e.g., 
schizophrenia, bipolar disorder, etc.), blindness, or the presence of acute infections, known cancer, or active 
corticoid treatment. The research complied with the requirements of the Declaration of Helsinki and the 
entire study protocol was approved by the local ethics committee at the University of Valencia (approval 
reference number: H1384175284261). All the participants signed a written informed consent form. A total 
of 62 (out 93 fulfilling inclusion criteria) patients from six different residences for the elderly signed the 
consent and thus, participated in the study. Sociodemographic and pharmacotherapeutic treatment data were 
collected, and the Charlson comorbidity index (Charlson et al., 1987) was calculated in order to quantify 
the burden of pluripathologies. 
2.2. Evaluation of subjective quality of sleep 
Sleep quality was measured using two validated tools: the Athens insomnia scale (Soldatos et al., 2000) and 
the Oviedo questionnaire (Bobes et al., 1998). Data were collected by trained personnel via face-to-face 
evaluations. The Athens insomnia scale (AIS) is a self-administered psychometric instrument designed to 
measure sleep difficulty based on the diagnostic criteria of the 10th revision of the international statistical 




population (Jiménez Genchi & Nenclares Portocarrero, 2005). It consists of eight items scored from 0 to 3: 
the higher the score, the greater the difficulty in sleeping. The first five factors are related to night-time 
sleep and the last three factors are related to daytime dysfunction. A cut-off score of ≥ 6 on the AIS is used 
to establish the diagnosis of insomnia (Soldatos et al., 2002). 
The Oviedo sleep quality questionnaire (SQQ) provides diagnostic help for insomnia- and hypersomnia-
type disorders according to the 4th edition of the diagnostic and statistical manual of mental disorders 
(DSM-IV) and ICD-10 criteria. The SQQ comprises 15 items; 13 are grouped into three subscales of: 
subjective sleep satisfaction (one item), insomnia (nine items), and hypersomnia (three items); the remaining 
two items give information about other organic alterations that can induce sleep disorders such as snoring 
with awakenings, nightmares, and restless legs syndrome, etc. and the use of non-prescription drugs or 
herbal infusions to induce sleep. The insomnia subscale explores different dimensions such as sleep latency, 
duration, efficiency, and diurnal dysfunction due to altered sleep.  
All the items are answered using a Likert-type scale from 1 to 5, except the subjective sleep satisfaction 
item (measured on a scale of 1 to 7). The questionnaire also provides a score of the severity of the insomnia 
(range: 9-45). 
2.3. Actigraphy 
Participants were recruited at their residences. A specialist nurse programmed the actigraph units, informed 
the patients about how to wear them, and downloaded the collected data. The actigraph devices were 
configured with 1-min epochs (i.e., a sampling length of one minute); the raw data collected from the 
actigraph is provided from its internal accelerometer. The accelerometer only provides proper acceleration 
the XYZ dimensions and so software is required to transform and analyze these data; in our case we used 
ActiLife® software.1 In particular, sleep was detected using the Cole–Kripke algorithm (CKA) available 
from ActiGraph® (Cole et al., 1992) because it is the most appropriate algorithm for older individuals 
(Actigraphcorp.com, 2015). For instance, the filled areas in the charts in Figure 1 representing sleep periods 
were determined with the CKA. 





 ActiLife® produces processed data that contains every single sleep period detected by the CKA for 
every patient. Of course, there may be several sleep periods for one patient within the same day. From this 
information, ActiLife® can generate different reports but, unfortunately, it does not allow us to further 
transform or manipulate the data displayed. We wanted to produce more sophisticated reports and so we 
developed a complementary software system to extract additional derived and aggregated information from 
the raw ActiLife® data files. This analyzer produces additional information including: average time spent 
asleep per day (including and excluding naps); average time spent in bed per day (including and excluding 
naps); total time spent in bed in a wakeful state per day.  The main information collected for each patient is 
summarized in Table 1. It includes the actigraphy information, the Oviedo and Athens questionnaire and 
blood and saliva test results, and the medical report on diseases, medications, etc. for each patient. 
Information on demographics, current and past diseases, medical conditions, prescription of drugs 
(including sleep medications), diagnosis of psychiatric and sleep disorders, as well as any daily activities 
that might affect sleep/wake behaviors were also collected.  
2.4. Measurement of cortisol 
Saliva samples were obtained in the morning between 9:00-11:00 a.m. in non-fasting conditions. Briefly, 
the procedure consisted of deproteinising 100 µL of saliva by adding 1000 µL dichloromethane; samples 
were gently agitated and centrifuged at 3500 rpm for 15 minutes at room temperature. The supernatant was 
collected, evaporated under nitrogen, and the residue was re-suspended in 100 µL of ethyl acetate. Cortisol 
concentrations were assessed by high-performance liquid chromatography coupled to mass spectroscopy. 
The concentration of cortisol (mg/dL) in the samples was extrapolated from a standard cortisol solution 
curve that covered the range of values found in the samples. The expert consensus on measuring waking 
cortisol states that at least three post-awakening cortisol samples are required from the same person on at 
least on two different days to determine the peak level (Stalder et al., 2016) and so, all the values in this 
study were obtained from the mean of three measurements made over a period of 11-15 days. All the 
reagents were purchased from Sigma-Aldrich. 
2.5 Statistical analysis 
The results are presented as the mean ± standard deviation, and the Shapiro–Wilk test was used to check for 
a normal data distribution. All the quantitative variables in the study had a non-normal distribution and so 




Kruskal–Wallis test and bivariate correlations between variables were evaluated using the Spearman 
correlation test as well as multivariable-adjusted statistical analyses. P values < 0.05 were considered to be 
statistically significant. All the statistical analyses were performed using SPSS software (version 20.0; 
SPSS, Inc., Chicago, IL). 
3. Results 
3.1. Clinical features of the sample 
We included an extensive demographic and medical information for each participant in order to analyse any 
possible association with the sleep variables. Regarding marital status, the sample was 19.51% single, 
14.63% married, 56.10% widowed, 2.44% divorced, and 7.32% with an ‘other’ status. Regarding 
pharmacotherapy with drugs which act at the level of central nervous system, 29.27% of the patients took 
antipsychotics, 41.46% took antidepressants, 48.78% took hypnotics, 43.9% took anxiolytics, 19.51% took 
antiepileptics, and 80.49% took opioids/analgesics. During the time the patients wore the actigraph units, 
each patient had been prescribed an average of 11.20 drugs, of which 3.28 acted on the central nervous 
system. The psycho-geriatric information about the sample, including the Barthel, Tinetti, and Mini-Mental 
scale results, is shown in Table 2.  
3.2. Evaluation of sleep by the Athens Scale and Oviedo questionnaire 
The results obtained using the Athens and Oviedo scales are summarized in Table 3. The mean Athens scale 
score was 4.00 ± 3.99 from a minimum score of 0 (no sleep disorder) and a maximum score of 16. According 
to the Athens Scale criteria, the presence of a sleep disorder is considered when the score is 6 or more 
(Soldatos et al., 2000) thus, according to this criterion, 20% of our patients had a sleep disorder.  
 Regarding the Oviedo scale, the total mean score was 29.48 ± 6.85; the average sleep satisfaction 
subscale (Oviedo subscale 1) score was 3.88 ± 2.11, where the patient’s subjective satisfaction with sleep 
ranged from 1 to 7, with higher numbers signifying higher satisfaction. On the other subscales, higher 
numbers signified more problematic sleep. The average insomnia subscale (Oviedo subscale 2) score was 
20.45 ± 6.89 and the average hypersomnia (Oviedo subscale 3) score was 5.15 ± 3.29; the average Oviedo 
subscale 4 (“sleep aid use or presence of adverse events during sleep”) score was 8.05 ± 3.43. As expected, 
there was a significant correlation between the Athens scale and the Oviedo subscale sleep satisfaction (rho 
= −0.51 p < 0.01, Spearman correlation test) and insomnia (rho = 0.62 p < 0.01, Spearman correlation test) 




scale could not be correlated to the Oviedo hypersomnia, sleep aid use subscales, or presence of adverse 
events during sleep because the former does not evaluate these items. However, age and the Charlson 
comorbidity index score did significantly correlate (rho = 0.32, P < 0.05, Spearman correlation test), 
although neither of them significantly correlated with the Athens scale or any of the Oviedo subscales; no 
significant correlation was found between age and sleep problems. 
3.3 Evaluation of sleep by actigraphy 
Each participant was asked to wear a wGT3X-BT® actigraph device for one week. After our initial data 
analysis, we discarded 11 patients because the data collected for them was anomalous—for example, they 
stopped wearing the actigraph unit for long periods of time which invalidated their data. Hence, the final 
sample was N = 41 patients [72% females, aged 63-97 years]. 
 The actigraph devices collected valuable objective data about the sleep patterns of our subjects (see 
Table 3). In particular, they indicated that among our patients the sleep efficiency (time asleep/time in bed) 
was 95.31% ± 2.57%, the total sleep time was 321.92 ± 105.84 minutes, the average number of awakenings 
during sleep was 5.47 ± 3.32, and the mean awakening length was 2.59 ± 1.01 minutes. 
3.4. Correlation between actigraphy and subjective evaluation of sleep 
In order to analyze the relationship between the objective sleep data recorded by actigraphy and the 
subjective quality of sleep the subjects reported via the Athens and Oviedo questionnaires, we analyzed the 
correlation between these variables. There was a significant and inverse correlation between the number of 
awakenings during the night assessed by actigraphy (Figure 2a) or the time spent awake during night (Figure 
2b) and the total Oviedo questionnaire score (rho = −0.32, p < 0.05, and rho = −0.37, p < 0.05, respectively). 
No significant effect was observed for the other actigraphy measurements and the other Oviedo 
questionnaire subscales or with the Athens scale score. However, there was a correlation between diagnosis 
of insomnia by the Athens questionnaire (AIS ≥ 6 (Soldatos et al., 2002)) and the number of awakenings 
during night and the time spent awake during the night (rho = −0.34, p < 0.05, and rho = −0.38, p < 0.05, 
respectively).  
 There was a significant and inverse correlation between age and total sleep time recorded by 




during sleeping (rho = −0.32 P < 0.05, Spearman correlation test; Figure 3b). The same correlation was 
observed in (Unruh et al., 2008). 
3.5. Correlation between actigraphy and cortisol concentration, Charlson index, and administered 
drugs 
We measured both the saliva and blood plasma cortisol concentrations (mg/dL) collected during the morning 
in order to study their relationship with the sleep in our targeted population, controlling for the collection 
time as a confounding variable. No significant correlation was observed between the saliva cortisol 
concentration and any of the sleep measurements, however blood plasma cortisol concentration significantly 
correlated with sleep time; in particular, patients that slept a mean of 4 hours or less presented high blood 
plasma cortisol concentrations (rho = 0.56, p < 0.01, Spearman correlation test). No significant effect was 
observed between the Charlson index score or the number of drugs administered daily.  
4. Discussion 
The International Classification of Sleep Disorders coined the term sleep state misperception to refer to 
people who wrongly perceive their sleep as wakefulness, or who severely overestimate their sleep time. 
This phenomenon has been studied for people aged 19-84 with insomnia and sleep apnea (Soldatos et al., 
2000), where the authors reported that the subjective perception of sleep does not necessarily match the 
objective measures for this population. In this work, we targeted another population for which sleep 
disorders are common: institutionalized elderly populations (aged over 62 years). Studies have shown that 
this population frequently experiences prolonged sleep latency, increased sleep fragmentation, and episodes 
of waking after sleep onset, more disturbed circadian rhythms, and night-day reversal (Meadows et al., 
2010). 
 Our study sample is particularly interesting because it is novel with respect to previous studies using 
actigraphy which targeted other populations and age groups such as children (aged 5-12) (Meltzer et al., 
2016), adults (aged 23-47) (Marino et al., 2013; Bianchi et al., 2013), patients with schizophrenia or bipolar 
disorder (Baandrup & Jennum, 2015), or elderly women (mean age 81.9 years) (Blackwell, 2008), among 
others (see (Martin & Hakim, 2011; Marino et al., 2013) for a comparison of these studies). This was the 
first study to include quantitative data regarding objective measures of sleep quality (sleep efficiency, total 
sleep time, number of awakenings, etc.) and cortisol concentrations, among the other variables studied (see 




targets the same population but studies other variables (inter-day stability, intra-day variability, relative 
amplitude of the activity rhythm, and mean level of activity during the 24-hour day). Thus, neither the 
sample population nor the Athens and Oviedo questionnaires have been used for this purpose in previous 
studies.  
 Our study reveals that the mean sleep time in this population is less than five and a half hours, and 
the average sleep efficiency is over 95%. This is slightly under the average (Ohayon et al., 2004), and far 
below expert recommendations (e.g., in the American National Sleep Foundation) of 7-8 hours a day for 
people older than 65 years. Regarding the subjective measurements, our study revealed a correlation 
between the subjective and objective perception of sleep in this population. In particular, the number of 
awakenings during the night and their total length correlates with both the SQQ scale score and the AIS 
diagnosis of insomnia. Therefore, we can conclude that both questionnaires are valid for the diagnosis of 
insomnia in this targeted population. It is, however, important to note that none of the Oviedo subscales 
were correlated with any sleep measurements, even the insomnia subscale. Similarly (Landry et al., 2015) 
incorporated a consensus sleep diary as the subjective measure of sleep and noted that these measurements 
survey different aspects of sleep quality compared to the objective measures. They concluded that an older 
adult’s perception of their sleep quality is quite different from the objective reality.  
Interestingly, (Chen et al., 2015) and (Klumpp et al., 2017) are similar studies which targeted different 
populations; while (Chen et al., 2015) looked at individuals with osteoarthritis, (Klumpp et al., 2017) 
targeted patients with social or generalized anxiety disorder, and/or major depressive disorder. These studies 
suggest that when considering a group of patients with specific diseases, the strength of correlation, if any, 
can vary considerably. In our sample, no correlation was found between the subjective perception of sleep 
and any of the psycho-geriatric information (Barthel, Tinetti, Mini-Mental test results) suggesting that sleep 
is not directly related to other alterations found in older individuals.  
 It is also worth noting the inverse correlation we found between age and the overall sleep time, which 
has been also reported in previous studies (Ohayon et al., 2004); this confirms that the need for and duration 
of sleep progressively decreases over time and with aging. The interaction of the hypothalamic-pituitary-
adrenal (HPA) axis with sleep is well-known and has been previously studied, e.g. (Leproult et al., 1997; 
Backhaus et al., 2004; Bush & Hudson, 2010). In particular, HPA axis hyperactivity can lead to shortened 
sleep time, among other sleep disorders (Bush & Hudson, 2010). This aligns with the correlation found in 




However, it is of note that sleep problems did not correlate with saliva cortisol concentrations. This contrasts 
with other studies such as (Backhaus et al., 2004), although these were performed in a younger population 
(aged 32-62 years). Hence, our findings strongly suggest that blood plasma rather than saliva cortisol 
concentrations should be used as a marker for detecting sleep problems for this older population, although 
longitudinal studies will still be required to fully understand any causal relationships in this regard.  
 While cortisol is essential for normal body function, among other consequences, sustained high 
levels of cortisol destroys healthy muscle and bone, interferes with healthy endocrine function, impairs 
digestion, slows down healing, normal cell regeneration, metabolism, and mental function, and weakens the 
immune system. Therefore, according to our findings, cortisol should be regularly measured in 
institutionalized individuals who sleep less than 4 hours. Detection of high levels of cortisol or shortened 
sleep times (< 4 hours) should trigger protocols to reduce anxiety and promote relaxation and sleep in this 
population. These protocols should include interventions to promote sleep hygiene and enhancement and 
management to provide a relaxing environment that favors comfort and, thus, sleep.  
 Among the measures which are fundamental for sleep hygiene in this population, of special 
importance are: (1) maintaining a regular sleep/wake schedule, (2) avoiding afternoon or evening napping, 
(3) avoiding forced sleep, (4) avoiding alcohol and caffeine in the evening, (5) avoiding stressful activities 
at bedtime, (6) minimizing annoying noise, light, or temperature extremes, (7) practicing relaxation 
exercises before going to bed, and (8) avoiding large meals. In addition, non-pharmacological interventions 
have also been shown to be effective at producing long-term changes in the sleep habits of individuals with 
chronic insomnia (Beltran et al., 2014; Bikowski et al., 2001) and different authors propose non-
pharmacological measures as the first-line treatment for insomnia (NANDA, 2014; Dochterman & 
Bulechek, 2007; Kalyanakrishan & Dewey, 2007). Thus, such measures should also be considered as a 
complement or alternative for elderly patients. 
 Apart from saliva cortisol concentrations, other variables such as the comorbidity index (Charlson 
index) or the number of drugs administered daily did not correlate with our actigraphy measurements 
suggesting that the disease burden of these patients may not be responsible for their sleep alterations or the 
cause of their sleep-related problems. Our results suggest that a thorough analysis of sleep-related 
impairment in older institutionalized individuals necessarily requires some clinical variables, such blood 
plasma cortisol concentrations (for people with very short nighttime sleep durations), be taken into account, 




order to control for variables that may be related to sleep quality. This complex analysis is crucial to be able 
to adequately tailor therapeutic strategies so that sleep quality can be improved in older institutionalized 
individuals in which poor sleep quality is a prevalent disorder. 
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In bed time 
Out bed time 
Efficiency 
Total time in bed 
Total sleep time 
Waking after sleep onset 
Number of awakenings 








Sleep Scales Morbidities Saliva/Blood Test 
Oviedo  
Athens 












Gender 72% F, 28% M 
 Mean 
Age 82.76 ± 8.70 
Barthel (performance in activities of daily living) 75.37 ± 21.31 (max 100) 
Tinetti (risk of falls) 22.29 ± 11.90 (max 28) 
Mini-Mental (dementia diagnosis) 26.25 ± 7.76 (max 35) 
















Athens Scale 4.00 ± 3.99  
Oviedo Subscale 1 (sleep satisfaction) 3.88 ± 2.11 
Oviedo Subscale 2 (insomnia) 20.45 ± 6.89 
Oviedo Subscale 3 (hypersomnia) 5.15 ± 3.29 
Oviedo Subscale 4 (organic alterations) 8.05 ± 3.43 
Oviedo Scale (Total Score) 29.48 ± 6.85 
Sleep Efficiency 95.14% ± 2.57% 
Total Sleep Time (min) 321.92 ± 105.84 
Number of Awakenings 5.47 ± 3.32 




Figure 1: Example of the activity recorded over one day with an wGT3X-BT® actigraph unit 
Figure 2: Correlation between the objective and subjective perception of sleep 
Figure 3: Correlation between age and sleep habits 
 
 
 
